Kevin J. McNamara - 31 Jul 2026 Form 4 Insider Report for CHEMED CORP (CHE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Aug 2026, 09:24:21 UTC
Prior SEC filing
04 May 2026
Next SEC filing
24 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Kevin J. McNamara

Key filing fact

Kevin J. McNamara filed Form 4 for CHEMED CORP (CHE) on 04 Aug 2026.

Key facts

  • This page summarizes Kevin J. McNamara's Form 4 filing for CHEMED CORP (CHE).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Aug 2026, 09:24.

Change

  • Previous filing in this sequence was filed on 04 May 2026.
  • Current net transaction value: -$1,079,020.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001207137 Primary reporting owner

MCNAMARA KEVIN J

Relationship
president and CEO, Director
Address
2600 CHEMED CENTER, 255 EAST 5TH STREET, CINCINNATI
Signature
Kevin J. McNamara
Signature date
04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CHE transaction

Capital Stock

Options Exercise

Transaction value
Shares
+2,001
Change %
+2.2%
Price
$445.35*
Shares after
92,220
Date
31 Jul 2026
Ownership
Direct
CHE transaction

Capital Stock

Tax liability

Transaction value
Shares
-19,802
Change %
-21%
Price
$529.22*
Shares after
72,418
Date
31 Jul 2026
Ownership
Direct
Footnotes
F1
CHE transaction

Capital Stock

Sale

Transaction value
$1,079,020
Shares
-2,000
Change %
-2.8%
Price
$539.51
Shares after
70,418
Date
03 Aug 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CHE transaction Derivative

Stock Option (right to buy with tandem tax withholding)

Options Exercise

Transaction value
Shares
-2,001
Change %
-0.75%
Price
$445.35*
Shares after
264,158
Date
03 Aug 2026
Ownership
Direct
Underlying class
Capital Stock
Underlying amount
2,001
Exercise price
$445.35
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Payment of purchase price and tax obligation on stock option exercise.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.59 to $543.50. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.

Footnote F3

Vesting in three equal annual installments commencing 10/28/2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .